Neuropeptide Y Attenuates Naloxone-Precipitated Morphine Withdrawal via Y5-like Receptors
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
The effects of intracerebroventricular injection of neuropeptide Y (NPY) and various NPY-related peptides were studied on naloxone-precipitated withdrawal from morphine in rats. The withdrawal reaction was assessed using an overall motor score, including jumping, wet dog shakes and other motor-related signs as well as a nonmotor score. At doses of 3, 6 or 12 nmol, NPY strongly and dose-dependently reduced the motor score. A less prominent inhibitory effect was revealed on the nonmotor score. At 6 nmol, [Leu31,Pro34]-NPY, NPY 3-36, peptide YY and human pancreatic polypeptide all significantly attenuated the motor score, whereas NPY 13-36 was without effect. This pharmacological profile suggests that the antiwithdrawal effect of NPY is mediated via the recently cloned Y5 receptor. Our data are consistent with a potential role for NPY and Y5-like receptors in basic mechanisms and as a therapeutic target in opioid dependence and withdrawal.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
The Rat Brain in Stereotaxic Coordinates
(1982) · Elsevier eBooks · doi:10.1016/c2009-0-63235-9 · Cited by 51,963
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,269 · cited 1×
“NPY is a 36 amino acid polypeptide that is widely and abundantly distributed in the central nervous system (Tatemoto et al., 1982).”
BackgroundThe anatomy of neuropeptide-y-containing neurons in rat brain
Chronwall, B. M., DiMaggio, D. A., Massari, V. J., Pickel, V. M., Ruggiero, D. A., & O'donohue, T. L. (1985) · Neuroscience · doi:10.1016/0306-4522(85)90260-x · Cited by 1,088
A receptor subtype involved in neuropeptide-Y-induced food intake
Gerald, C., Walker, M. W., Criscione, L., Gustafson, E. L., Batzl-Hartmann, C., Smith, K. E., Vaysse, P., Durkin, M. M., Laz, T. M., Linemeyer, D. L., et al. (1996) · Nature · doi:10.1038/382168a0 · Cited by 891 · cited 4×
“Because Y5 receptors are mainly located in the central nervous system (Gerald et al., 1996), Y5 agonists may turn out to have only few peripheral side effects.”
InfluentialStanley, B. G., & Leibowitz, S. F. (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.11.3940 · Cited by 741 · cited 1×
“Thus the powerful feeding stimulatory effect of NPY (Levine and Morley, 1984; Stanley and Leibowitz, 1985) appears to be mediated via hypothalamic Y5 receptors (Gerald et al., 1996).”
Kainic acid seizures in the rat
Sperk, G. (1994) · Progress in Neurobiology · doi:10.1016/0301-0082(94)90019-1 · Cited by 688 · cited 2×
“The exact location of these " antiseizure receptors " remains to be determined, but the hippocampus is one likely possibility, because this region contains a high concentration of Y5 mRNA (Gerald et al., 1996) and is considered a primary focus of kainic acid seizures (Sperk, 1994).”
de Quidt, M. E., & Emson, P. C. (1986) · Neuroscience · doi:10.1016/0306-4522(86)90057-6 · Cited by 569
Neuropeptide Y: A potent inducer of consummatory behavior in rats
Levine, A. S., & Morley, J. E. (1984) · Peptides · doi:10.1016/0196-9781(84)90165-7 · Cited by 561 · cited 2×
“Thus the powerful feeding stimulatory effect of NPY (Levine and Morley, 1984; Stanley and Leibowitz, 1985) appears to be mediated via hypothalamic Y5 receptors (Gerald et al.”
Y-receptor subtypes—how many more?
Blomqvist, A. G., & Herzog, H. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(96)01057-0 · Cited by 529 · cited 1×
“However, the Y6 receptor gene is absent from the rat genome (Blomqvist and Herzog, 1997).”
Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides
Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. (1993) · Science · doi:10.1126/science.8380941 · Cited by 527 · cited 1×
“Although previous studies have ascribed this anxiolytic effect of NPY to Y1 receptors (Heilig et al., 1993; Wahlestedt et al., 1993), these studies do not rule out involvement of Y5 receptors.”
Background
Research works printed but not linked: 2
- Gustafson, 1996, Localization of the mRNA encoding a novel NPY receptor subtype in rat brain., Soc Neurosci Abstr, 22, 1682
- Pich, 1990, Effects of central administration of neuropeptide Y on vigilance and pain threshold in spontaneously hypertensive rats., Adv Pain Res Ther, 13, 55
Cited by
Drug Addiction, Dysregulation of Reward, and Allostasis
Koob, G. (2001) · Neuropsychopharmacology · doi:10.1016/s0893-133x(00)00195-0 · Cited by 2,953
“Neuropeptide Y (NPY), a 36 amino acid member of the pancreatic polypeptide family, also has been implicated in the neuroadaptations associated with the development of drug addiction.”
BackgroundInfluentialA Role for Brain Stress Systems in Addiction
Koob, G. F. (2008) · Neuron · doi:10.1016/j.neuron.2008.06.012 · Cited by 1,056
“NPY and NPY peptide analogs administered intracerebroventricularly decreased naloxone-precipitated withdrawal in rats (Woldbye et al., 1998).”
Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development
Koob, G. F. (2021) · Pharmacological Reviews · doi:10.1124/pharmrev.120.000083 · Cited by 337
“However, NPY administration attenuated somatic withdrawal symptoms that were produced during naloxone-precipitated withdrawal from chronic opioids (Woldbye et al., 1998; Clausen et al., 2001).”
BackgroundTobacco addiction and the dysregulation of brain stress systems
Bruijnzeel, A. W. (2012) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2012.02.015 · Cited by 173
“N IH -PA Author M anuscript N IH -PA Author M anuscript N IH -PA Author M anuscript addition, NPY and other NPY receptor agonists such as [Leu31, Pro34]-NPY, NPY 3–36, and peptide YY decrease somatic opioid withdrawal signs in rats (Woldbye et al., 1998).”
BackgroundResultNeuropeptide Y and its receptors as potential therapeutic drug targets
Silva, A. P., Cavadas, C., & Grouzmann, E. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00301-7 · Cited by 168
Metadata
- Authors
- Woldbye, D. P. D., Klemp, K., & Madsen, T. M.
- Affiliations
- University of Copenhagen (DK)
- Corresponding author
- Woldbye, David P.D.
- Venue
- The Journal of Pharmacology and Experimental Therapeutics
- Publisher
- Elsevier BV
- Published
- 1998-02
- Volume
- 284
- Issue
- 2
- Pages
- 633-636
- ISSN
- 0022-3565 (ISSN-L)
- OpenAlex
- W2236442418
- Cited by
- 54
- References
- 40
- Citations by year
- 2025: 1 · 2023: 3 · 2022: 1 · 2021: 3 · 2020: 1 · 2017: 2 · 2016: 1 · 2015: 1 · 2013: 4 · 2012: 3
- FWCI
- 1.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- Locations
- Journal of Pharmacology and Experimental Therapeutics (publishedVersion)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
- PubMed
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- neuropeptide Y, morphine withdrawal, naloxone-precipitated withdrawal, Y5 receptor, opioid use disorder, peptide YY, pancreatic polypeptide, intracerebroventricular administration
- MeSH terms
- Animals, Dose-Response Relationship, Drug, Male, Morphine, Motor Activity, Naloxone, Neuropeptide Y, Structure-Activity Relationship, Substance Withdrawal Syndrome, Rats, Wistar, Receptors, Neuropeptide Y, Peptide YY, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Neuropeptide Y Attenuates Naloxone-Precipitated Morphine Withdrawal via Y5-like Receptors. https://app.cochat.ai/papers/10.1016/s0022-3565(24)37249-0
- The paper
- Woldbye, D. P. D., Klemp, K., & Madsen, T. M. (1998). Neuropeptide Y Attenuates Naloxone-Precipitated Morphine Withdrawal via Y5-like Receptors. The Journal of Pharmacology and Experimental Therapeutics. https://doi.org/10.1016/s0022-3565(24)37249-0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.